Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Skin Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Temporarily pausedNCT01988831
What this trial is testing

Efficacy of Propranolol Treatment to Prevent Melanoma Progression

Who this might be right for
Stages III Skin MelanomaStages II Skin MelanomaStage IB Skin Melanoma
University Hospital, Geneva 450
Not applicableStudy completedNCT03717402
What this trial is testing

Smartphone Technology to Alleviate Malignant Pain (STAMP)

Who this might be right for
CancerPain ManagementOpioid Use
Dana-Farber Cancer Institute 20
Early research (Phase 1)Looking for participantsNCT06010862
What this trial is testing

Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors

Who this might be right for
Gastric CancerColon CancerPancreas Cancer+4 more
Chongqing Precision Biotech Co., Ltd 36
Early research (Phase 1)Study completedNCT01656642
What this trial is testing

A Phase 1b Study of Atezolizumab in Combination With Vemurafenib or Vemurafenib Plus Cobimetinib in Participants With BRAFV600-Mutation Positive Metastatic Melanoma

Who this might be right for
Malignant Melanoma
Genentech, Inc. 67
Testing effectiveness (Phase 2)WithdrawnNCT03739606
What this trial is testing

Flotetuzumab in Treating Patients With Recurrent or Refractory CD123 Positive Blood Cancer

Who this might be right for
Acute Biphenotypic LeukemiaAcute LeukemiaChronic Myelogenous Leukemia, BCR-ABL1 Positive+12 more
City of Hope Medical Center
Early research (Phase 1)Active Not RecruitingNCT07118176
What this trial is testing

Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers

Who this might be right for
Anal CarcinomaBladder CarcinomaBreast Carcinoma+31 more
Jonsson Comprehensive Cancer Center 30
Not applicableStudy completedNCT05757427
What this trial is testing

Pilot Clinical Evaluation of a Microwave Imaging System for Breast Cancer Detection

Who this might be right for
Breast Cancer
MVG Industries SAS 73
Not applicableUnknownNCT05836246
What this trial is testing

The Development of Quantitative Ultrasound Imaging Software Platform

Who this might be right for
Chronic Liver DiseaseThyroid DiseaseBenign Breast Disease+2 more
Seoul National University Bundang Hospital 196
Not applicableLooking for participantsNCT04534127
What this trial is testing

Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia

Who this might be right for
Skin CancerMucosal Neoplasm of Oral CavitySoft Tissue Neoplasm
Alpha Tau Medical LTD. 56
Not applicableUnknownNCT06493786
What this trial is testing

Identification of Olfactory Biomarkers of Skin Cancer From Skin Odor Samples: a Pilot Study

Who this might be right for
Identify Volatile Biomarkers Specific to Malignant Melanoma, Basal Cell Carcinoma and Squamous Cell CarcinomaVerify That the Volatile Biomarkers Identified Derive From Metabolic Changes in Body Odour and Not Just From Changes in the Surface of Cancerous Lesions
Association pour la Recherche Clinique et Immunologique 120
Early research (Phase 1)Ended earlyNCT01519323
What this trial is testing

BRIM-P: A Study of Vemurafenib in Pediatric Patients With Stage IIIC or Stage IV Melanoma Harboring BRAFV600 Mutations

Who this might be right for
Malignant Melanoma
Hoffmann-La Roche 6
Testing effectiveness (Phase 2)Study completedNCT02304458
What this trial is testing

Nivolumab With or Without Ipilimumab in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Sarcomas

Who this might be right for
Metastatic MelanomaRecurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal TumorRecurrent Hodgkin Lymphoma+20 more
National Cancer Institute (NCI) 140
Large-scale testing (Phase 3)Study completedNCT01748448
What this trial is testing

Vitamin D Supplementation in Cutaneous Malignant Melanoma Outcome

Who this might be right for
Cutaneous Malignant Melanoma
Universitaire Ziekenhuizen KU Leuven 436
Testing effectiveness (Phase 2)Active Not RecruitingNCT02978625
What this trial is testing

Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers

Who this might be right for
Anaplastic Large Cell Lymphoma, ALK-NegativeAnaplastic Large Cell Lymphoma, ALK-PositiveApocrine Carcinoma+36 more
National Cancer Institute (NCI) 68
Early research (Phase 1)Active Not RecruitingNCT04483778
What this trial is testing

B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults

Who this might be right for
Pediatric Solid TumorGerm Cell TumorRetinoblastoma+14 more
Seattle Children's Hospital 68
Early research (Phase 1)UnknownNCT05539157
What this trial is testing

Study to Evaluate JCXH-211 as Monotherapy in Patients With Malignant Solid Tumors

Who this might be right for
Cutaneous TumorMalignant Solid Tumor
Immorna Biotherapeutics, Inc. 1
Not applicableLooking for participantsNCT05620329
What this trial is testing

UNC Pleural Fluid Registry

Who this might be right for
Lung CancerLung InfectionBreast Cancer+2 more
UNC Lineberger Comprehensive Cancer Center 9,999
Large-scale testing (Phase 3)Study completedNCT01720407
What this trial is testing

Relevance of Imiquimod as Neo-adjuvant Treatment to Reduce Excision Size and the Risk of Intralesional Excision in Lentigo Malignant of the Face

Who this might be right for
Lentigo Maligna Melanoma (Head or Neck)
Nantes University Hospital 259
Large-scale testing (Phase 3)Study completedNCT02180867
What this trial is testing

Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery

Who this might be right for
Alveolar Soft Part SarcomaAngiomatoid Fibrous HistiocytomaAtypical Fibroxanthoma+33 more
National Cancer Institute (NCI) 140
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06297811
What this trial is testing

Myeloprotection With Trilaciclib in Pan-cancer Population

Who this might be right for
Non-Small Cell Lung CancerBreast CancerEndometrial Cancer+2 more
Sun Yat-sen University 132
Next Page